Share

Mexico participates in Walvax COVID-19 vaccine trials

Media Dec 7, 2021 adn40

Trials of the Walvax vaccine against COVID-19 are being carried out in Mexico. The product is based on the mRNA, same as the moderna and pfizer vaccines. It is a biologic developed in China and 6,000 volunteers over 18 years of age are being recruited nationally.

Related Links

HPV vaccine manufacturers commit to provide enough supply to immunise at least 84 million girls in Gavi countries

Walvax Shares Vaccine Development Expertise at 11th National Vaccine Conference of Thailand

Walvax publishes safety and non-inferior immunogenicity results of its MPV ACYW135 compared with Menactra® in Human Vaccines & Immunotherapeutics